NSE - Delayed Quote INR

Abbott India Limited (ABBOTINDIA.NS)

Compare
29,909.30
+368.40
+(1.25%)
At close: 3:30:03 PM GMT+5:30
Loading Chart for ABBOTINDIA.NS
  • Previous Close 29,540.90
  • Open 29,800.00
  • Bid --
  • Ask --
  • Day's Range 29,740.00 - 30,398.00
  • 52 Week Range 25,200.00 - 31,898.95
  • Volume 10,986
  • Avg. Volume 15,365
  • Market Cap (intraday) 652.008B
  • Beta (5Y Monthly) 0.05
  • PE Ratio (TTM) 47.53
  • EPS (TTM) 629.22
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield 410.00 (1.39%)
  • Ex-Dividend Date Jul 19, 2024
  • 1y Target Est 29,838.57

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

www.abbott.co.in

3,814

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ABBOTINDIA.NS

View More

Performance Overview: ABBOTINDIA.NS

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ABBOTINDIA.NS
0.57%
S&P BSE SENSEX (^BSESN)
2.36%

1-Year Return

ABBOTINDIA.NS
13.58%
S&P BSE SENSEX (^BSESN)
3.27%

3-Year Return

ABBOTINDIA.NS
76.53%
S&P BSE SENSEX (^BSESN)
28.71%

5-Year Return

ABBOTINDIA.NS
98.54%
S&P BSE SENSEX (^BSESN)
176.52%

Compare To: ABBOTINDIA.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ABBOTINDIA.NS

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    628.40B

  • Enterprise Value

    610.15B

  • Trailing P/E

    47.04

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.06

  • Price/Book (mrq)

    17.83

  • Enterprise Value/Revenue

    9.78

  • Enterprise Value/EBITDA

    32.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.38%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    62.43B

  • Net Income Avi to Common (ttm)

    13.34B

  • Diluted EPS (ttm)

    629.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.06B

  • Total Debt/Equity (mrq)

    1.72%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ABBOTINDIA.NS

View More

Company Insights: ABBOTINDIA.NS

Research Reports: ABBOTINDIA.NS

View More

People Also Watch